Low-dose thalidomide plus monthly high-dose oral dexamethasone (Thali-Dexa): results, prognostic factors and side effects in eight patients previously treated with multiple myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/16767919

Download in:

View as

General Info

PMID
16767919